Literature DB >> 31022109

Nomograms to identify elevated blood pressure values and left ventricular hypertrophy in a paediatric population: American Academy of Pediatrics Clinical Practice vs. Fourth Report/European Society of Hypertension Guidelines.

Laura Antolini1, Marco Giussani2, Antonina Orlando1, Elisa Nava1, Maria G Valsecchi1, Gianfranco Parati1,3, Simonetta Genovesi1,3.   

Abstract

OBJECTIVE AND METHODS: The study aimed at evaluating, in a large sample of Italian children, the reclassification of blood pressure categories with the new U.S. nomograms, obtained in a population of normal-weight children (American Academy of Pediatrics Clinical Practice Guidelines, AAP-CPG), compared with the Fourth Report/European Society of Hypertension (ESH) nomograms. The performance of the two classifications in identifying the presence of left ventricular hypertrophy was also assessed.
RESULTS: In 951 individuals referred to a Pediatric Center for Cardiovascular Risk Prevention, a 12% increase in the prevalence of children with blood pressure at least 90th percentile was observed by using the new nomograms. In the subsample of children aged at least 13 years, the application of the blood pressure fixed cutoff values of 120/<80 mmHg (for 'elevated' blood pressure) and of 130/80 mmHg (for hypertension) led to a change in the blood pressure category (worse or better) in about 30% of cases as compared with the AAP-CPG classification based on percentiles. Regarding the identification of individuals with left ventricular hypertrophy, the AAP-CPG classification led to an increase in the true positive fraction (sensitivity) of 5.5%, and to an increment of the false-positive fraction (1 - specificity) of 5.8%. The logistic regression model, adjusted for possible confounding factors, and the ROC curves obtained from the linear predictor of the model showed an identical performance of the Fourth Report/ESH and the AAP-CPG classifications.
CONCLUSION: In our paediatric population, the AAP-CPG classification slightly increased the prevalence of elevated blood pressure values compared with the Fourth Report/ESH classification. Moreover, the application of more 'physiological' nomograms, based on a population of normal-weight children, did not yield any advantage in identifying individuals with early cardiac organ damage.

Entities:  

Mesh:

Year:  2019        PMID: 31022109     DOI: 10.1097/HJH.0000000000002069

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

1.  Re-evaluating hypertension in children according to different guidelines: a single-center study.

Authors:  Cemaliye Basaran; Belde Kasap Demir; Mustafa Agah Tekindal; Gokcen Erfidan; Ozgur Ozdemir Simsek; Secil Arslansoyu Camlar; Caner Alparslan; Demet Alaygut; Fatma Mutlubas; Ferhan Elmali
Journal:  Hypertens Res       Date:  2022-04-01       Impact factor: 3.872

Review 2.  Subclinical Organ Damage in Children and Adolescents with Hypertension: Current Guidelines and Beyond.

Authors:  Denise Marcon; Angela Tagetti; Cristiano Fava
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-10-24

3.  Hypertension in Children and Adolescents: A Position Statement From a Panel of Multidisciplinary Experts Coordinated by the French Society of Hypertension.

Authors:  Béatrice Bouhanick; Philippe Sosner; Karine Brochard; Claire Mounier-Véhier; Geneviève Plu-Bureau; Sébastien Hascoet; Bruno Ranchin; Christine Pietrement; Laetitia Martinerie; Jean Marc Boivin; Jean Pierre Fauvel; Justine Bacchetta
Journal:  Front Pediatr       Date:  2021-07-07       Impact factor: 3.418

Review 4.  Impact of the 2017 American Academy of Pediatrics' Clinical Practice Guideline on the Identification and Risk Stratification of Youth at Increased Cardiovascular Disease Risk.

Authors:  Tammy M Brady; Kathleen Altemose; Elaine M Urbina
Journal:  Hypertension       Date:  2021-04-05       Impact factor: 9.897

5.  Reclassification of adolescent hypertension by ambulatory blood pressure monitoring using adult norms and association with left ventricular hypertrophy.

Authors:  Jessica Fallon Campbell; Shweta Shah; Poyyapakkam Srivaths; Alisa A Acosta
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-09       Impact factor: 3.738

6.  Difference in the Prevalence of Elevated Blood Pressure and Hypertension by References in Korean Children and Adolescents.

Authors:  Jeong Yeon Kim; Heeyeon Cho; Jae Hyun Kim
Journal:  Front Med (Lausanne)       Date:  2022-02-24

7.  Association of obesity phenotypes with left ventricular mass index and left ventricular hypertrophy in children and adolescents.

Authors:  Simonetta Genovesi; Elena Tassistro; Marco Giussani; Giulia Lieti; Ilenia Patti; Antonina Orlando; Massimo Montemerlo; Laura Antolini; Gianfranco Parati
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

Review 8.  Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping Review.

Authors:  Beate Aurich; Evelyne Jacqz-Aigrain
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.